Trodelvy User Reviews & Ratings
Trodelvy has an average rating of 6.8 out of 10 from a total of 4 reviews on Drugs.com. 75% of reviewers reported a positive experience, while 25% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Breast Cancer | 4 reviews for Breast Cancer | 82 medications |
- Jan...
- Taken for 1 to 6 months
- January 19, 2024
For Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"
- sil...
- Taken for 6 months to 1 year
- December 5, 2024
For Breast Cancer "It helped to have good PET scans and to shrink tumors in my chest."
Frequently asked questions
- Sta...
- Taken for 1 to 6 months
- April 24, 2024
For Breast Cancer "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Trodelvy (sacituzumab govitecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."